查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559694

良性攝護腺增生治療設備的全球市場

Benign Prostatic Hyperplasia Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年，全球良性前列腺增生治療設備市場預計將達到8.165億美元

良性攝護腺增生治療設備的全球市場預計 2023 年為 5.828 億美元，預計到 2030 年將達到 8.165 億美元，2023-2030 年分析期間複合年成長率為 4.9%。醫院最終用途是本報告分析的細分市場之一，預計複合年成長率為 5.3%，到分析期結束時將達到 4.969 億美元。在分析期間，泌尿系統診所最終用途細分市場的複合年成長率預計為 4.4%。

美國市場預估為1.585億美元，中國預期複合年成長率為4.7%

預計2023年美國良性前列腺增生治療設備市場規模將達1.585億美元。中國作為世界第二大經濟體，預計2030年市場規模將達到1.295億美元，2023-2030年分析期間複合年成長率為4.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 4.7% 和 4.1%。在歐洲，德國的複合年成長率預計為 4.9%。

全球良性前列腺增生治療設備市場—主要趨勢與促進因素總結

前列腺增生治療儀在現代治療中扮演什麼角色？

良性攝護腺增生 (BPH) 治療設備是治療良性攝護腺增生的重要工具，提供微創解決方案，可顯著減少與此情況相關的症狀和併發症，這種情況在老年男性中很常見。這些設備是傳統手術方法的替代方案，可以實現更有針對性、對患者友善的治療。 BPH治療設備包括多種技術，包括經尿道前列腺切除術（TURP）設備、雷射治療系統、前列腺支架以及蒸汽療法和前列腺尿道提升（PUL）系統等新治療方法。透過移除或重新定位阻塞尿道的多餘前列腺組織，這些裝置可以改善尿流並緩解相關症狀，例如頻尿和閉尿症。這些先進設備的引入擴大了男性的選擇範圍，從而可以根據其特定的健康需求和恢復目標制定更個人化的治療策略。

技術創新如何提高 BPH 治療設備的有效性？

技術創新顯著提高了 BPH 治療設備的療效和安全性，從而改善了患者預後並提供了更廣泛的治療選擇。鈥雷射前列腺切割術(HoLEP) 等雷射治療系統利用精密雷射技術以微創方式去除多餘的組織，從而降低與傳統手術方法相關的風險。蒸汽療法等創新治療方法利用水蒸氣收縮前列腺組織，是非侵入性的，可提供良好的長期效果。此外，前列腺尿道提升 (PUL) 系統的發展徹底改變了 BPH 治療，提供了一種無需切割或切除前列腺組織即可物理重新定位的方法，從而保留性功能並保證更快的恢復。這些進步不僅提高了 BPH 治療的成功率，而且還使其更容易獲得且對患者生活的干擾更少，從而鼓勵更多的男性尋求此類創新解決方案。

為什麼整個醫療保健系統對 BPH 治療設備的需求不斷增加？

由於幾個重要趨勢，整個醫療保健系統對 BPH 治療設備的需求正在迅速增加。由於全球老年人口的不斷成長，前列腺增生症的盛行率不斷增加，這增加了對有效和微創治療方案的需求。 BPH 治療設備特別有吸引力，因為當今的患者資訊更加豐富，通常更喜歡恢復時間更短、風險更低的門診手術。人們對 BPH 症狀的認知不斷提高，以及先進治療方案的出現，促使更多男性儘早醫，並增加了對 BPH 治療設備的需求。此外，轉向以價值為基礎的醫療保健模式，重點是改善患者的治療效果，同時降低成本，這促使醫療保健提供者採用可以提供高品質、高效護理的 BPH 治療設備，這是我正在推動的。這些因素導致 BPH 設備的使用增加，這些設備正在成為現代泌尿系統醫學的一個組成部分。

推動BPH設備市場成長的關鍵因素是什麼？

BPH 治療設備市場的成長受到多種因素的推動，包括老齡化人口中 BPH 盛行率的增加以及需要治療的患者人數的增加。醫療技術的發展，特別是雷射治療和前列腺尿道提升系統等微創手術的發展，也透過提供更安全、更有效的治療選擇來推動市場成長。人們越來越偏好門診治療，這可以減少住院時間和醫療費用，進一步推動了這些設備的採用。此外，人們對 BPH 及其對生活品質影響的認知不斷提高，導致更多男性尋求早期療育，從而增加了對創新 BPH 治療設備的需求。隨著這些趨勢的持續發展，在持續的技術創新和對有效且患者友好的治療解決方案日益成長的需求的支持下，良性前列腺增生設備市場預計將出現強勁成長。

受訪企業範例（38家知名企業）

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP10675

Global Benign Prostatic Hyperplasia Devices Market to Reach US$816.5 Million by 2030

The global market for Benign Prostatic Hyperplasia Devices estimated at US$582.8 Million in the year 2023, is expected to reach US$816.5 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$496.9 Million by the end of the analysis period. Growth in the Urology Clinics End-Use segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$158.5 Million While China is Forecast to Grow at 4.7% CAGR

The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$158.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$129.5 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Benign Prostatic Hyperplasia Devices Market - Key Trends and Drivers Summarized

What Role Do Benign Prostatic Hyperplasia Devices Play in Modern Treatment?

Benign Prostatic Hyperplasia (BPH) devices are essential tools in the management of prostate enlargement, offering minimally invasive solutions that significantly reduce the symptoms and complications associated with this common condition in aging men. These devices provide alternatives to traditional surgical approaches, enabling more targeted and patient-friendly treatments. BPH devices include a range of technologies such as transurethral resection of the prostate (TURP) instruments, laser therapy systems, prostatic stents, and newer treatments like water vapor therapy and prostatic urethral lift (PUL) systems. By either removing or repositioning excess prostate tissue that blocks the urethra, these devices improve urinary flow and alleviate related symptoms like frequent urination and urinary retention. The introduction of these advanced devices has expanded the options available to men, allowing for more personalized treatment strategies that align with their specific health needs and recovery goals.

How Are Technological Innovations Enhancing BPH Device Effectiveness?

Technological innovations have significantly enhanced the effectiveness and safety of BPH devices, leading to better patient outcomes and broader treatment options. Laser therapy systems, such as holmium laser enucleation of the prostate (HoLEP), leverage precision laser technology to remove excess tissue with minimal invasiveness, reducing the risks associated with traditional surgical methods. Innovations like water vapor therapy, which utilizes steam to shrink prostate tissue, offer a non-invasive alternative with excellent long-term results. Additionally, the development of prostatic urethral lift (PUL) systems has revolutionized BPH treatment by providing a method to physically reposition the prostate tissue without cutting or removing it, thus preserving sexual function and ensuring quicker recovery. These advancements are not only improving the success rates of BPH treatments but also making them more accessible and less disruptive to patients' lives, encouraging more men to seek out these innovative solutions.

Why Is There Increasing Demand for BPH Devices Across Healthcare Systems?

The demand for BPH devices is rapidly increasing across healthcare systems due to several key trends. The growing elderly population worldwide is leading to a higher incidence of BPH, creating a greater need for effective, minimally invasive treatment options. Patients today are more informed and often prefer outpatient procedures that offer shorter recovery times and lower risks, which makes BPH devices particularly appealing. Increased awareness about BPH symptoms and the availability of advanced treatment options are prompting more men to seek medical attention earlier, thereby boosting the demand for these devices. Additionally, the shift towards value-based healthcare models, which focus on improving patient outcomes while reducing costs, is driving healthcare providers to adopt BPH devices that can deliver high-quality, efficient care. These factors are contributing to the growing utilization of BPH devices, which are becoming an integral part of modern urological care.

What Are the Key Factors Driving the Growth of the BPH Devices Market?

The growth in the BPH devices market is driven by several factors, including the rising prevalence of BPH among the aging population, which is expanding the pool of patients requiring treatment. Advances in medical technology, particularly in the development of less invasive procedures such as laser therapies and prostatic urethral lift systems, are also fueling market growth by offering safer, more effective treatment options. The increasing preference for outpatient care, which reduces hospitalization time and healthcare costs, is further boosting the adoption of these devices. Additionally, heightened awareness of BPH and its impact on quality of life is leading more men to seek early intervention, thus driving demand for innovative BPH devices. As these trends continue to evolve, the BPH devices market is expected to experience robust growth, supported by ongoing technological innovations and the rising demand for effective, patient-friendly treatment solutions.

Select Competitors (Total 38 Featured) -

  • Biolitec, Inc.
  • Boston Scientific Corporation
  • Lumenis Be Ltd.
  • Olympus Corporation
  • UK MEDS DIRECT Limited
  • Urologix, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Benign Prostatic Hyperplasia Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of BPH Among Aging Males Spurs Growth in BPH Devices Market
    • Increasing Preference for Outpatient Treatments Expands Addressable Market for BPH Devices
    • Growing Demand for Effective Long-Term Management Strengthens the Business Case for BPH Devices
    • Expansion of Urology Clinics and Specialized Centers Drives Adoption of BPH Devices
    • Advancements in Laser and Thermal Therapies Generate New Opportunities in BPH Devices Market
    • Push for Shorter Recovery Times Drives Demand for Minimally Invasive BPH Devices
    • Growing Use of BPH Devices in Geriatric Care Spurs Innovation in Treatment Technologies
    • Increasing Importance of Post-Treatment Monitoring Accelerates Adoption of Advanced BPH Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for TURP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for TURP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Laser Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Laser Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Urology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Urology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Benign Prostatic Hyperplasia Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Benign Prostatic Hyperplasia Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Benign Prostatic Hyperplasia Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by Procedure - TURP, Laser Therapy and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by Procedure - Percentage Breakdown of Value Sales for TURP, Laser Therapy and Other Procedures for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Benign Prostatic Hyperplasia Devices by End-Use - Hospitals, Urology Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Benign Prostatic Hyperplasia Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Urology Clinics and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030

IV. COMPETITION